Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10786482 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US9669008 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US10772868 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US11040023 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US11173141 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US11141405 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US10039745 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US9808442 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) | |
US10154987 | AZURITY | Enalapril formulations |
Mar, 2036
(13 years from now) |
Market Authorisation Date: 20 September, 2016
Treatment: Method of treatment of heart failure; Treatment of heart failure; Method of treating hypertension; Method of treating left ventricular dysfunction; Treatment of hypertension
Dosage: SOLUTION;ORAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8778366 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) | |
US9968553 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) | |
US8568747 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) | |
US9855214 | SILVERGATE PHARMS | Enalapril compositions |
Nov, 2032
(9 years from now) |
Market Authorisation Date: 13 August, 2013
Treatment: Treatment of hypertension; Method of treatment of heart failure; Method of treating hypertension; Treatment of heart failure; Method of treating left ventricular dysfunction
Dosage: FOR SOLUTION;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic